Left Menu
Development News Edition

WRAPUP 4-AstraZeneca resumes U.S. COVID-19 vaccine trial and J&J prepares to do same

J&J paused its large, late-stage trial last week after a study participant became ill and the company said an independent safety panel was investigating.

Reuters | Washington DC | Updated: 24-10-2020 02:44 IST | Created: 24-10-2020 02:02 IST
WRAPUP 4-AstraZeneca resumes U.S. COVID-19 vaccine trial and J&J prepares to do same
Representative image. Image Credit: Twitter (@AstraZeneca)

AstraZeneca Plc has resumed the U.S. trial of its experimental COVID-19 vaccine after approval by regulators, and Johnson & Johnson is preparing to resume its trial as well, the companies said on Friday.

AstraZeneca's U.S. trial was paused on Sept. 6 after a report of a serious neurological illness, believed to be transverse myelitis, in a participant in the company's UK trial. J&J paused its large, late-stage trial last week after a study participant became ill and the company said an independent safety panel was investigating. J&J said on Friday that the safety panel, called a Data and Safety Monitoring Board, has recommended that the drugmaker resume trial recruitment after finding no evidence that the vaccine caused the volunteer to fall ill.

J&J is preparing to resume its trial in the United States and is in discussions with other regulators to resume a trial outside of the United States as well, it said. So far, the medical board has not identified a clear cause for the patients' illness.

AstraZeneca trials in the United Kingdom, Brazil and South Africa resumed last month even as the U.S. Food and Drug Administration continued its investigation into the case. Reuters earlier this week reported that the FDA had completed its review and that the AstraZeneca U.S. trial was set to resume as early as this week, citing four sources familiar with the situation.

AstraZeneca's vaccine is being developed along with researchers at Oxford University.


TRENDING

OPINION / BLOG / INTERVIEW

Turbulence surrounding tobacco control in Ghana

... ...

Smart healthcare: IoT redefining the way healthcare is delivered

As the world is embracing the new wave of digitalization triggered by the pandemic and the arrival of 5G, the adoption of IoT devices will further boom. With adoption set to soar, IoT security issues and other challenges cant be ignored any...

Refugee compassion and response: Ideas to mitigate disasters now and in their future

Their homeland becomes a forbidden territory for them and more likely than not, their journey to foreign soil is no less traumatizing, not to say deadly. It is crucial to help refugees live a life of dignity and purpose....

Inadequate water infrastructure causes a tidal wave of coronavirus in rural Alaska

... ...

Videos

Latest News

Trump senior aide Kushner and team heading to Saudi Arabia, Qatar

White House senior adviser Jared Kushner and his team are headed to Saudi Arabia and Qatar this week for talks in a region simmering with tension after the killing of an Iranian nuclear scientist.A senior administration official said on Sun...

Soccer-Lennon under pressure as Celtic's slide gathers pace

Celtics slump continued when they were dumped out of the Scottish League Cup by Ross County on Sunday as manager Neil Lennon admitted it was time for some soul searching.The 2-0 second-round home loss, Celtics first in a domestic cup since ...

Motor racing-Grosjean has 'miracle' escape from fiery Bahrain crash

Romain Grosjean leaped to safety in a miracle escape after his Haas car was ripped in half and engulfed in flames in a first-lap accident that halted Sundays Bahrain Formula One Grand Prix. The 34-year-old Frenchman, who was able to free hi...

Motor racing-Brawn says halo saved Grosjean in horrific, fiery crash

Romain Grosjean walked away from a fiery crash that split his car in two at the Bahrain Grand Prix on Sunday in a miracle escape that owed as much to Formula Ones never-ending quest for safety as luck.Ross Brawn, Formula Ones managing direc...

Give Feedback